KHOLOUD NABIL ISMAIL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner GARDEN CITY, MI NPI 1821780222
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MI Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$1,722.14
- Category: General Payments
- Program years: PY2023–2024
- Record count: 77
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,309.11 across 57 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,210.11 | 56 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $172.31 | 7 |
| Takeda Pharmaceuticals U.S.A., Inc. | $165.97 | 7 |
| Celgene Corporation | $150.89 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $100.20 | 4 |
| Karyopharm Therapeutics Inc. | $86.46 | 3 |
| Genentech USA, Inc. | $81.10 | 4 |
| EMD Serono, Inc. | $42.34 | 2 |
| PharmaEssentia USA Corporation | $41.51 | 2 |
| Tempus AI, Inc | $39.60 | 2 |
| Lilly USA, LLC | $39.44 | 2 |
| SOBI, INC | $39.39 | 2 |
| Janssen Biotech, Inc. | $38.03 | 1 |
| BeiGene USA, Inc. | $36.23 | 2 |
| ABBVIE INC. | $28.35 | 1 |
| GENZYME CORPORATION | $27.80 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $25.87 | 1 |
| TerSera Therapeutics LLC | $25.27 | 1 |
| JAZZ PHARMACEUTICALS INC. | $23.37 | 1 |
| Incyte Corporation | $22.88 | 1 |
| Gilead Sciences, Inc. | $21.29 | 1 |
| Astellas Pharma US Inc | $20.48 | 1 |
| Janssen Pharmaceuticals, Inc | $19.56 | 1 |
| SHIELD THERAPEUTICS INC | $15.51 | 1 |
| Regeneron Healthcare Solutions, Inc. | $15.37 | 1 |
| Acerta Pharma LLC | $15.31 | 1 |
| Merck Sharp & Dohme Corporation | $14.58 | 1 |
By program year
Records — PY2024 (57)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.